Table 2.
Cancer | CircRNA | Gene of Origin | Interactions | Effect | Reference |
---|---|---|---|---|---|
Breast cancer | circ_0006528 | PRELID2 | miR-7-5p | Promotes cancer progression | [86] |
circ-WWC3 | WWC3 | miR-26b-3p, miR-660-3p |
[87] | ||
Ovarian | circ-ITCH | ITCH | miR-145-5p/RASA1 | Suppresses cancer progression | [88] |
circ-PIP5K1A | PIP5K1A | miR-661/IGFBP5 | Promotes cancer progression | [78] | |
circ_102958 | - | miR-1205/SH2D3A | [89] | ||
Cervical cancer | circ-SMARCA5 | SMARCA5 | miR-432-5p | Promotes cell proliferation | [90] |
circ-AGFG1 | AGFG1 | miR-370-3p/RAF1 | Promotes cancer progression | [80] | |
Clear Cell Renal Cell Carcinoma | circ-APBB1IP | APBB1IP | - | Promotes cancer progression | [91] |
Bladder cancer | circ-CEP128 | CEP128 | miR-145-5p/MYD88 | Promotes cancer progression | [92] |
circ-VANGL1 | VANGL1 | miR-1184/IGFBP2 | [79] | ||
Colorectal cancer | circ_102209 | - | miR-761/RIN1 | Promotes cell growth and metastasis | [76] |
circITGA7 | ITGA7 | miR-370-3p/NF1/ RREB1/ITGA7 |
Suppresses tumor growth and metastasis | [75] | |
Gastric cancer | circ_0032821 | CEP128 | - | Promotes cell proliferation and metastasis | [93] |
circ-PDSS1 | PDSS1 | miR-186-5p/NEK2 | Promotes cancer progression | [82] | |
circ-DLST | DLST | miR-502-5p/ NRAS/MAP2K1/MAPK1,miR-502-5p/ NRAS/MAP2K1/MAPK3 | [81] | ||
Hepatocellular carcinoma | circ-ASAP1 | ASAP1 | miR-326/MAPK1, miR-532-5p/MAPK1 |
Promotes cancer progression | [94] |
Non-small cell lung cancer | circ-FOXM1 | FOXM1 | miR-1304-5p/PPDPF, miR-1304-5p/MACC1 |
Promotes cancer progression and metastasis | [95] |
circ-ZKSCAN1 | ZKSCAN1 | miR-330-5p/FAM83A | Promotes cancer progression | [83] |